162 related articles for article (PubMed ID: 16566566)
1. Effect of recombinant platelet-derived growth factor (Regranex) on wound closure in genetically diabetic mice.
Chan RK; Liu PH; Pietramaggiori G; Ibrahim SI; Hechtman HB; Orgill DP
J Burn Care Res; 2006; 27(2):202-5. PubMed ID: 16566566
[TBL] [Abstract][Full Text] [Related]
2. Research of PDGF-BB gel on the wound healing of diabetic rats and its pharmacodynamics.
Li H; Fu X; Zhang L; Huang Q; Wu Z; Sun T
J Surg Res; 2008 Mar; 145(1):41-8. PubMed ID: 18082770
[TBL] [Abstract][Full Text] [Related]
3. PDGF and FGF stimulate wound healing in the genetically diabetic mouse.
Greenhalgh DG; Sprugel KH; Murray MJ; Ross R
Am J Pathol; 1990 Jun; 136(6):1235-46. PubMed ID: 2356856
[TBL] [Abstract][Full Text] [Related]
4. PDGF and TGF-alpha act synergistically to improve wound healing in the genetically diabetic mouse.
Brown RL; Breeden MP; Greenhalgh DG
J Surg Res; 1994 Jun; 56(6):562-70. PubMed ID: 8015312
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human platelet-derived growth factor enhanced dermal wound healing by a pathway involving ERK and c-fos in diabetic rats.
Cheng B; Liu HW; Fu XB; Sun TZ; Sheng ZY
J Dermatol Sci; 2007 Mar; 45(3):193-201. PubMed ID: 17270401
[TBL] [Abstract][Full Text] [Related]
6. [Experimental study on recombinant human platelet-derived growth factor gel in a diabetic rat model of cutaneous incisal wound healing].
Sun TZ; Fu XB; Zhao ZL; Chen W; Sun XQ; Zhou G; Shen ZY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2003 Oct; 15(10):596-9. PubMed ID: 14552680
[TBL] [Abstract][Full Text] [Related]
7. Adenoviral mediated gene transfer of PDGF-B enhances wound healing in type I and type II diabetic wounds.
Keswani SG; Katz AB; Lim FY; Zoltick P; Radu A; Alaee D; Herlyn M; Crombleholme TM
Wound Repair Regen; 2004; 12(5):497-504. PubMed ID: 15453831
[TBL] [Abstract][Full Text] [Related]
8. Promoting healing with recombinant human platelet-derived growth factor--BB in a previously irradiated problem wound.
Hom DB; Manivel JC
Laryngoscope; 2003 Sep; 113(9):1566-71. PubMed ID: 12972935
[TBL] [Abstract][Full Text] [Related]
9. Topical platelet-derived growth factor in patients enhances wound closure in the absence of wound contraction.
Ehrlich HP; Freedman BM
Cytokines Cell Mol Ther; 2002; 7(3):85-90. PubMed ID: 12850807
[TBL] [Abstract][Full Text] [Related]
10. Effects of vascular endothelial growth factor on wound closure rates in the genetically diabetic mouse model.
Kirchner LM; Meerbaum SO; Gruber BS; Knoll AK; Bulgrin J; Taylor RA; Schmidt SP
Wound Repair Regen; 2003; 11(2):127-31. PubMed ID: 12631300
[TBL] [Abstract][Full Text] [Related]
11. Accelerated healing of excisional skin wounds by PL 14736 in alloxan-hyperglycemic rats.
Seveljević-Jaran D; Cuzić S; Dominis-Kramarić M; Glojnarić I; Ivetić V; Radosević S; Parnham MJ
Skin Pharmacol Physiol; 2006; 19(5):266-74. PubMed ID: 16785777
[TBL] [Abstract][Full Text] [Related]
12. PDGF and FGF reverse the healing impairment in protein-malnourished diabetic mice.
Albertson S; Hummel RP; Breeden M; Greenhalgh DG
Surgery; 1993 Aug; 114(2):368-72; discussion 372-3. PubMed ID: 8342137
[TBL] [Abstract][Full Text] [Related]
13. [Becaplermin gel (Regranex gel)].
Senet P
Ann Dermatol Venereol; 2004 Apr; 131(4):351-8. PubMed ID: 15258509
[TBL] [Abstract][Full Text] [Related]
14. Adenosine A2A receptor agonists promote more rapid wound healing than recombinant human platelet-derived growth factor (Becaplermin gel).
Victor-Vega C; Desai A; Montesinos MC; Cronstein BN
Inflammation; 2002 Feb; 26(1):19-24. PubMed ID: 11936752
[TBL] [Abstract][Full Text] [Related]
15. Enhancement by PL 14736 of granulation and collagen organization in healing wounds and the potential role of egr-1 expression.
Tkalcević VI; Cuzić S; Brajsa K; Mildner B; Bokulić A; Situm K; Perović D; Glojnarić I; Parnham MJ
Eur J Pharmacol; 2007 Sep; 570(1-3):212-21. PubMed ID: 17628536
[TBL] [Abstract][Full Text] [Related]
16. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells.
Galiano RD; Tepper OM; Pelo CR; Bhatt KA; Callaghan M; Bastidas N; Bunting S; Steinmetz HG; Gurtner GC
Am J Pathol; 2004 Jun; 164(6):1935-47. PubMed ID: 15161630
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers.
Steed DL
Plast Reconstr Surg; 2006 Jun; 117(7 Suppl):143S-149S; discussion 150S-151S. PubMed ID: 16799381
[TBL] [Abstract][Full Text] [Related]
18. Human plasma fibronectin potentiates the mitogenic activity of platelet-derived growth factor and complements its wound healing effects.
Larivière B; Rouleau M; Picard S; Beaulieu AD
Wound Repair Regen; 2003; 11(1):79-89. PubMed ID: 12581430
[TBL] [Abstract][Full Text] [Related]
19. Priming with a combination of proangiogenic growth factors enhances wound healing in streptozotocin-induced diabetes in mice.
Ackermann M; Wolloscheck T; Wellmann A; Li VW; Li WW; Konerding MA
Eur Surg Res; 2011; 47(2):81-9. PubMed ID: 21720165
[TBL] [Abstract][Full Text] [Related]
20. Priming with a combination of proangiogenic growth factors improves wound healing in normoglycemic mice.
Ackermann M; Wolloscheck T; Wellmann A; Li VW; Li WW; Konerding MA
Int J Mol Med; 2011 May; 27(5):647-53. PubMed ID: 21373751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
